NDC 0002-8213 Humalog Tempo Pen
Insulin Lispro Injection, Solution Subcutaneous
Product Information
Product Packages
NDC Code 0002-8213-05
Package Description: 5 SYRINGE in 1 CARTON / 3 mL in 1 SYRINGE (0002-8213-01)
Price per Unit: $33.92045 per ML
Product Details
What is NDC 0002-8213?
The NDC code 0002-8213 is assigned by the FDA to the product Humalog Tempo Pen which is a human prescription drug product labeled by Eli Lilly And Company. The generic name of Humalog Tempo Pen is insulin lispro. The product's dosage form is injection, solution and is administered via subcutaneous form. The product is distributed in a single package with assigned NDC code 0002-8213-05 5 syringe in 1 carton / 3 ml in 1 syringe (0002-8213-01). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.
What are the uses for Humalog Tempo Pen?
Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).
What are Humalog Tempo Pen Active Ingredients?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
- INSULIN LISPRO 100 [iU]/mL - Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.
Which are Humalog Tempo Pen UNII Codes?
The UNII codes for the active ingredients in this product are:
- INSULIN LISPRO (UNII: GFX7QIS1II)
- INSULIN LISPRO (UNII: GFX7QIS1II) (Active Moiety)
Which are Humalog Tempo Pen Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- GLYCERIN (UNII: PDC6A3C0OX)
- SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM (UNII: GR686LBA74)
- METACRESOL (UNII: GGO4Y809LO)
- ZINC (UNII: J41CSQ7QDS)
- PHENOL (UNII: 339NCG44TV)
- WATER (UNII: 059QF0KO0R)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- TROMETHAMINE (UNII: 023C2WHX2V)
What is the NDC to RxNorm Crosswalk for Humalog Tempo Pen?
RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
- RxCUI: 1652239 - insulin lispro 200 UNT/ML in 3 ML Pen Injector
- RxCUI: 1652239 - 3 ML insulin lispro 200 UNT/ML Pen Injector
- RxCUI: 1652242 - HumaLOG 200 UNT/ML in 3 ML Pen Injector
- RxCUI: 1652242 - 3 ML insulin lispro 200 UNT/ML Pen Injector [Humalog]
- RxCUI: 1652242 - 3 ML Humalog 200 UNT/ML Pen Injector
Which are the Pharmacologic Classes for Humalog Tempo Pen?
A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.
* Please review the disclaimer below.
Patient Education
Insulin Lispro Injection
Insulin lispro injection products are used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). Insulin lispro injection products are also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood) who need insulin to control their diabetes. In patients with type 1 diabetes, insulin lispro injection products are always used with another type of insulin, unless it is used in an external insulin pump. In patients with type 2 diabetes, insulin lispro injection products may be used with another type of insulin or with oral medication(s) for diabetes. Insulin lispro injection products are a short-acting, manmade version of human insulin. Insulin lispro injection products work by replacing the insulin that is normally produced by the body and by helping move sugar from the blood into other body tissues where it is used for energy. They also stops the liver from producing more sugar. Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Using medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease.Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
[Learn More]
* Please review the disclaimer below.
Product Label
We have moved the product label and warning information to a dedicated page, please follow the link below:
View Product Label